Stay updated on Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial
Sign up to get notified when there's something new on the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page.

Latest updates to the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page
- Check2 days agoChange DetectedThe webpage has updated its date references, adding new dates in March 2025 while removing older dates from December 2024 and January 2025.SummaryDifference0.3%
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.5%
- Check48 days agoChange DetectedThe website has updated to revision v2.14.2, noting that some NLM-NCBI services are experiencing heavy traffic, potentially impacting performance and availability.SummaryDifference0.6%
- Check70 days agoChange DetectedThe primary analysis of the RMS phase 3 study (MS200527_0082) led to its early termination, with results indicating the safety and efficacy of evobrutinib in relapsing multiple sclerosis, while previous results showing it did not meet its primary endpoint have been removed.SummaryDifference72%
- Check77 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check99 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
Stay in the know with updates to Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evobrutinib in RMS: EvolutionRMS 2 Clinical Trial page.